Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis

NCT00432653 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: rituximab

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]